Crovalimab,Eculizumab
Roche,Chugai Pharmaceutical,AstraZeneca
['rova,(-approval),(-microvascular)', 'commodore1']
lots of new #pnh data at the #eha2023 oral #bmfsm session! presented data from the commodore1 study looking at patients with tx #pnh on c5 inhibitors; received crovalimab versus eculizumab. disease controlled on both arms. no increase in side effects. 1/3 
🇮🇪🧛🏻‍♀️Haematologist @nih_nhlbi l via  @ucdmedicine @trinitymed1 l Lover of 🚀🐷🖖🍷l #SAA #IBMFS #telomeres #CHIP #MDS #AML #HSCT #VEXAS l Comments mine.